Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report

BACKGROUND: The treatment options for metastatic malignant melanoma have drastically changed recently,including the increased use of immunotherapeutic agents that offer significant responses. Accordingly, it hasbecome common for sequential administration of such agents. Despite this, no guidelines e...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Joseph I., Bufalino, Shams, Singh, Shruti, Borys, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001027/
https://www.ncbi.nlm.nih.gov/pubmed/29898784
http://dx.doi.org/10.1186/s40425-018-0370-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001027/
https://www.ncbi.nlm.nih.gov/pubmed/29898784
http://dx.doi.org/10.1186/s40425-018-0370-6

Ejemplares similares